Astellas unveils smartphone application for radionuclide imaging

Astellas Pharma has launched an application for smartphones that will allow physicians to have access to the appropriate use criteria for cardiac radionuclide imaging when assessing patients' imaging needs. The criteria were based on guidelines developed by various groups, including SNM and ASNC.